Print this page    •   Back to Web version of article

Microbicide HIV Prevention for Women -- Ring or Gel?

November 5, 2012

Research reported on PubMed.gov finds that the effectiveness of vaginal microbicides for preventing HIV infection depends on the method of administration, and different methods may be better for different drugs. Macaques prepared with the experimental non-nucleoside reverse transcriptase inhibitor (NNRTI) MIV-150 administered in a carageenan gel experienced more than 80% protection when challenged with the simian analogue to HIV. The closely related NNRTI MIV-160 was ineffective adminstered in gel but was highly effective when administered in a slow-release vaginal ring.

We wonder whether a vaginal ring that stays inserted for a week or a month might not be a better, less compliance-dependent means of protection for women who can't negotiate condom use with their partners.




This article was provided by National Association of People With AIDS. It is a part of the publication Positive Voice. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/69756/microbicide-hiv-prevention-for-women--ring-or-gel.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.